A novel potent oral series of VEGFR2 inhibitors abrogate tumor growth by inhibiting angiogenesis.
Guido Bold,Christian Schnell,Pascal Furet,Paul McSheehy,Josef Brüggen,Jürgen Mestan,Paul W Manley,Peter Drückes, Marion Burglin, Ursula Dürler,Jacqueline Loretan, Robert Reuter,Markus Wartmann,Andreas Theuer,Beatrice Bauer-Probst,Georg Martiny-Baron,Peter Allegrini,Arnaud Goepfert,Jeanette Wood,Amanda Littlewood-Evans JOURNAL OF MEDICINAL CHEMISTRY（2016）
关键词
angiogenesis,tumor growth,novel potent oral series,inhibitors
AI 理解论文
溯源树
样例
